CAJ | 학술논문

目的：探讨抗炎合剂治疗上呼吸道感染的疗效与及其对炎症因子的影响。方法将120例上呼吸道感染患者随机分为两组，抗炎合剂组和常规治疗组，于治疗后第3天观察疗效，第1和第5天分别用ELISA法和免疫层析法检测白介素-1和降钙素原水平。结果抗炎合剂组临床总有效率比较高，复诊率比较低，IL-1明显下降，较常规治疗组明显(P<0.05)，降钙素原治疗前后无明显变化，两组也无差别(P>0.05)。结论抗炎合剂治疗上呼吸道感染临床效果明显，并能抑制IL-1水平。
목적：탐토항염합제치료상호흡도감염적료효여급기대염증인자적영향。방법장120례상호흡도감염환자수궤분위량조，항염합제조화상규치료조，우치료후제3천관찰료효，제1화제5천분별용ELISA법화면역층석법검측백개소-1화강개소원수평。결과항염합제조림상총유효솔비교고，복진솔비교저，IL-1명현하강，교상규치료조명현(P<0.05)，강개소원치료전후무명현변화，량조야무차별(P>0.05)。결론항염합제치료상호흡도감염림상효과명현，병능억제IL-1수평。
Objective To investigate The clinical effect and impact on inflammatory factors by Anti-inflammatory agent treatment in upper respiratory tract infection patients Methods 120 patients with upper respiratory tract infection were randomly divided into two groups, anti-inflammatory agent group and the conventional treatment group.The clinical effect was observed three days later.On the 1st and 5th day after the treatment began, IL-1 and PCT were respectively detected by ELISA and immunochromatography assay.Results Clinical effective rate is relatively higher, referral rate is relatively lower, IL-1 significantly decreased, in the Anti-inflammatory agents group than the conventional treatment group (P <0.05).PCT was not significant change before and after treatment, and no Difference between the two groups (P > 0.05)Conclusion The anti-inflammatory agents can inhibit IL-1 levels,and the clinical effect is obvious in the upper respiratory infection patients.